(Q30376306)

21 June 2017

title

Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. (English)

1 reference

21 June 2017

0 references

Jacco Wallinga

3

0 references

author name string

Anna K Lugnér

series ordinal

1

1 reference

21 June 2017

Sido D Mylius

series ordinal

2

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

19

1 reference

21 June 2017

issue

5

1 reference

21 June 2017

page(s)

518-531

1 reference

Precautionary behavior in response to perceived threat of pandemic influenza.

21 June 2017

cites work

1 reference

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

21 January 2018

1 reference

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

21 January 2018

1 reference

7 January 2021

Choices, beliefs, and infectious disease dynamics

1 reference

7 January 2021

Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts

1 reference

7 January 2021

Estimating influenza-related hospitalization in The Netherlands

1 reference

7 January 2021

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

1 reference

7 January 2021

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

1 reference

7 January 2021

Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis

1 reference

7 January 2021

An introduction to Markov modelling for economic evaluation

1 reference

7 January 2021

A taxonomy of model structures for economic evaluation of health technologies.

1 reference

7 January 2021

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

7 January 2021

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

7 January 2021

The friction-cost method : replacement for nothing and leisure for free?

1 reference

7 January 2021

Do we fully understand the economic value of vaccines?

1 reference

7 January 2021

Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.

1 reference

7 January 2021

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

7 January 2021

Poverty, death, and a future influenza pandemic.

1 reference

7 January 2021

Strategies for containing an emerging influenza pandemic in Southeast Asia

1 reference

7 January 2021

Mitigation strategies for pandemic influenza in the United States.

1 reference

7 January 2021

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

1 reference

7 January 2021

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

7 January 2021

The friction cost method for measuring indirect costs of disease.

1 reference

7 January 2021

Containing pandemic influenza at the source.

1 reference

7 January 2021

Antiviral resistance and the control of pandemic influenza

1 reference

7 January 2021

Antiviral agents for influenza: a comparison of cost-effectiveness data

1 reference

7 January 2021

A model to estimate the potential economic benefits of measles eradication for the United States.

1 reference

7 January 2021

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

1 reference

7 January 2021

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

1 reference

7 January 2021

Cost-effectiveness analyses of human papillomavirus vaccination

1 reference

7 January 2021

The epidemiology and clinical impact of pandemic influenza.

1 reference

7 January 2021

Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study

1 reference

7 January 2021

Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults

1 reference

7 January 2021

Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination.

1 reference

7 January 2021

Productivity-cost controversies in cost-effectiveness analysis: review and research agenda

1 reference

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

7 January 2021

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

1 reference

7 January 2021

How generation intervals shape the relationship between growth rates and reproductive numbers.

1 reference

7 January 2021

Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents.

1 reference

7 January 2021

Appropriate models for the management of infectious diseases

1 reference

7 January 2021

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

7 January 2021

Costs and effects of chlamydial screening: dynamic versus static modeling

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.1485

1 reference

21 June 2017

1 reference